{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 0.16350307, "regularMarketPrice": 30.63, "exchange": "NGM", "shortName": "Arcturus Therapeutics Holdings ", "longName": "Arcturus Therapeutics Holdings Inc.", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 10.179, "fiftyDayAverage": 23.0792, "fiftyDayAverageChange": 7.5507984, "fiftyDayAverageChangePercent": 0.32716897, "twoHundredDayAverage": 18.87, "twoHundredDayAverageChange": 11.759998, "twoHundredDayAverageChangePercent": 0.6232113, "marketCap": 813624640, "forwardPE": -11.386617, "priceToBook": 3.0091364, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683664200, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingPE": 92.81818, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.33, "epsForward": -2.69, "epsCurrentYear": -2.05, "priceEpsCurrentYear": -14.941463, "sharesOutstanding": 26563000, "firstTradeDateMilliseconds": 1369229400000, "priceHint": 2, "regularMarketChange": 0.049999237, "regularMarketTime": 1684180804, "regularMarketDayHigh": 31.61, "regularMarketDayRange": "30.16 - 31.61", "regularMarketDayLow": 30.16, "regularMarketVolume": 468123, "regularMarketPreviousClose": 30.58, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 10, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 30.65, "averageDailyVolume3Month": 526483, "averageDailyVolume10Day": 529640, "fiftyTwoWeekLowChange": 18.93, "fiftyTwoWeekLowChangePercent": 1.6179488, "fiftyTwoWeekRange": "11.7 - 33.8", "fiftyTwoWeekHighChange": -3.17, "fiftyTwoWeekHighChangePercent": -0.093786985, "fiftyTwoWeekLow": 11.7, "fiftyTwoWeekHigh": 33.8, "dividendDate": 1510790400, "marketState": "PRE", "displayName": "Arcturus Therapeutics", "symbol": "ARCT"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "10628 Science Center Drive", "address2": "Suite 250", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 170, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 50, "title": "Founder, Pres, CEO & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 1134000, "fmt": "1.13M", "longFmt": "1,134,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1964641, "fmt": "1.96M", "longFmt": "1,964,641"}}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula", "age": 43, "title": "Founder, Chief Scientific Officer, COO & Sec.", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": {"raw": 787500, "fmt": "787.5k", "longFmt": "787,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1296346, "fmt": "1.3M", "longFmt": "1,296,346"}}, {"maxAge": 1, "name": "Mr. Andrew H. Sassine MBA", "age": 58, "title": "CFO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 826875, "fmt": "826.88k", "longFmt": "826,875"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1803777, "fmt": "1.8M", "longFmt": "1,803,777"}}, {"maxAge": 1, "name": "Mr. Keith C. Kummerfeld CPA", "title": "Sr. VP of Fin. & Corp. Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Dushyant B. Varshney Ph.D.", "title": "Exec. VP & Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "VP and Head of IR/PR & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}